TEARS FOR LIFE

Tears for Life, LLC is a medical diagnostic equipment company that is developing a non-invasive tear test kit that will reliably screen women for breast cancer using proteins found in women’s tears. Globally, the tear test kit has a potential market size approaching $50 billion per year and will reduce the economic burden of treatment of breast cancer by up to $28 billion per year. With health care reform and breast cancer awareness being prominent issues, this test will be the core of a profitable portfolio of non-invasive diagnostic tests that will save lives and significantly reduce health care costs.